Invivyd, Inc. (IVVD)
0.6022
+0.04
(+6.96%)
USD |
NASDAQ |
Nov 09, 14:13
Invivyd Total Assets (Quarterly) : 218.88M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 218.88M |
| March 31, 2026 | 241.74M |
| December 31, 2025 | 276.88M |
| September 30, 2025 | 139.16M |
| June 30, 2025 | 89.14M |
| March 31, 2025 | 103.74M |
| December 31, 2024 | 129.52M |
| September 30, 2024 | 161.92M |
| June 30, 2024 | 177.35M |
| March 31, 2024 | 215.47M |
| December 31, 2023 | 229.18M |
| September 30, 2023 | 274.92M |
| Date | Value |
|---|---|
| June 30, 2023 | 315.41M |
| March 31, 2023 | 350.56M |
| December 31, 2022 | 383.17M |
| September 30, 2022 | 424.75M |
| June 30, 2022 | 484.61M |
| March 31, 2022 | 556.27M |
| December 31, 2021 | 620.09M |
| September 30, 2021 | 686.27M |
| June 30, 2021 | 397.99M |
| March 31, 2021 | 94.87M |
| December 31, 2020 | 117.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 106.22M |
| Armata Pharmaceuticals, Inc. | 89.95M |
| Voyager Therapeutics, Inc. | 177.05M |
| Black Diamond Therapeutics, Inc. | 125.03M |
| Elicio Therapeutics, Inc. | 39.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.80M |
| Shareholders Equity (Quarterly) | 181.08M |
| Debt to Equity Ratio | 0.0463 |
| Current Ratio | 5.869 |
| Net Debt Paydown Yield | -0.58% |